Download PDF
Nervenheilkunde 2006; 25(06): 430-436
DOI: 10.1055/s-0038-1626481
Originaler Artikel
Schattauer GmbH

Psychiatrische Komorbidität bei Erwachsenen mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung

Eine ÜbersichtPsychiatric comorbidity in adults with attention deficit hyperactivity disorderAn overview
E. Sobanski
1   Klinik für Psychiatrie und Psychotherapie, Zentralinstitut für Seelische Gesundheit, Mannheim (Direktor: Prof. Dr. Dr. F. Henn)
› Author Affiliations
Further Information

Publication History

Publication Date:
19 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) ist eine chronische Erkrankung, die im Kindesalter beginnt und sich bei bis zu 50% der Betroffenen ins Erwachsenenalter fortsetzt. Die ADHS des Erwachsenenalters geht mit Einschränkungen der Alltagsbewältigung in verschiedenen Lebensbereichen und einer hohen Rate weiterer psychiatrischer Erkrankungen einher. Bis zu 89% aller Erwachsenen mit ADHS leiden im Laufe ihres Lebens unter einer oder mehreren weiteren psychiatrischen Erkrankungen, insbesondere affektiven Störungen, Suchterkrankungen und Persönlichkeitsstörungen. Dies kompliziert das klinische Bild der Erkrankung und ihre Behandlung. Ziel der vorliegenden Übersicht ist es, entsprechend der aktuellen Studienlage wesentliche Ergebnisse zur Prävalenz, Klinik und zu ätiologischen Modellen von komorbiden psychiatrischen Erkrankungen bei der ADHS des Erwachsenenalters darzustellen und Implikationen für das klinische Vorgehen zu besprechen.

Summary

Attention deficit hyperactivity disorder (ADHD) is a chronic disorder, which begins in childhood and continues into adulthood in up to 50% of the patients. ADHD in adults results in impairment in several areas of life and is often associated with comorbid psychiatric disorders. Up to 89% of all adults with ADHD suffer from one or more additional psychiatric disorders during lifetime, mainly affective disorders, substance related disorders and personality disorders. The presented overview aims to delineate essential scientific results concerning prevalence, clinical picture and as far as available etiologies of comorbid psychiatric disorders in adult ADHD and to discuss implications for clinical setup.

Schlüsselwörter

Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Erwachsenen - affektive Störungen - Angsterkrankungen - Abhängigkeitserkrankungen - Persönlichkeitsstörungen

Keywords

Adult attention deficit hyperactivity disorder (ADHD) - affective disorders - anxiety disorders - substance use disorders - personality disorders
 

  • Literatur

  • 1 Weiss G. et al. Psychiatric status of hyperactives as adults: A controlled prospective 15-year followup of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 1985; 24: 211-23.
    CrossrefGoogle Scholar
  • 2 Manuzza S, Klein RG, Bessler A, Malloy P, La Padula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993; 50: 565-7.
    CrossrefGoogle Scholar
  • 3 Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: A controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 2000; 39: 1424-31.
    CrossrefGoogle Scholar
  • 4 Murphy KR, Barkley RA, Bush T. Young adults with attention-deficit hyperactivity disorder: subtype differences in comorbidity, education and clinical history. J Nerv Ment Dis 2002; 190: 147-57.
    CrossrefGoogle Scholar
  • 5 Secnik K, Swenson A, Lange MJ. Comorbidities and costs of adults with attention-deficit hyperactivity disorder. Pharmacoeconomics 2005; 23: 93-102.
    CrossrefGoogle Scholar
  • 6 Kessler RC. Prevalence of adult ADHD in the United States: Results from the National Comorbidity Survey Replication (NCS-R). Data presented during the APA annual meeting. New York: 2004
    Google Scholar
  • 7 Kooij JJS, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit / hyperactivity disorder. A randomized placebo-controlled trial. Psychol Medicine 2004; 34: 973-82.
    CrossrefGoogle Scholar
  • 8 Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J. et al. A large double-blind, randomized trial of methylphenidate in the treatment of adults with attention-deficit / hyperactivity disorder. Biol Psychiatry 2005; 57: 456-63.
    CrossrefGoogle Scholar
  • 9 Vermeiren R, de Clippele A, Deboutte D. A descriptive survey of Flemish delinquent adolescents. J Adolesc 2000; 23: 277-89.
    CrossrefGoogle Scholar
  • 10 Rösler M, Retz W, Retz-Junginger P, Hensch G, Schneider M, Supprian T. Eur Arch Psychiatry Clin Neurosc. 2004; 254: 365-71.
    Google Scholar
  • 11 Biederman J. et al. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence. Biol Psychiatry 1998; 44: 269-73.
    CrossrefGoogle Scholar
  • 12 Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA. et al. Patterns of psychiatric comorbidity and psychosocial functioning in adults with attention deficit hyperactivity disorder. AmJ Psychiatry 1993; 150: 1792-7.
    Google Scholar
  • 13 Biederman J. et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152: 1652-8.
    CrossrefGoogle Scholar
  • 14 Wilens TE. et al. Attention deficit hyperactivity disorder (ADHD) is associated with early-onset substance use disorders. J Nerv Ment Dis 1997; 185: 475-82.
    CrossrefGoogle Scholar
  • 15 Clure C, Brady KT, Saladin ME. et al. Attentiondeficit/hyperactivity disorder: symptom pattern and drug choice. Am J Drug Alcohol Abuse 1999; 25: 441-8.
    CrossrefGoogle Scholar
  • 16 Schubiner H, Tzelepis A, Millberger S. et al. Prevalence of attention-deficit/hyperactivity disorder among substance use disorders. J Clin Psychiatry 2000; 61: 244-51.
    CrossrefGoogle Scholar
  • 17 Wodarz N, Laufkötter R, Lange K, Johann N. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei erwachsenen Alkoholabhängigen. Nervenheilkunde 2004; 09: 527-33.
    Article in Thieme ConnectGoogle Scholar
  • 18 Sullivan MA, Rudnik-Levin F. Attention deficit/ hyperactivity disorder and substance abuse. Annals of NY Acad Sci 2000; ð: 251-70.
    Google Scholar
  • 19 Carroll KM, Rounsaville KJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993; 34: 75-83.
    CrossrefGoogle Scholar
  • 20 Biederman J. Pharmacotherapy of attention deficit hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. J Clin Psychiatry 2003; 64 (Suppl. 11) 3-8.
    Google Scholar
  • 21 Wilens TE. Impact of ADHD and its treatment on substance use disorders. J Clin Psychiatry 2004; 65: 38-45.
    Google Scholar
  • 22 Wilens TE, Biederman J, Prince J. et al. Six-week, double-blind, placebo-controlled study of desipramine for adults with attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153: 1147-53.
    CrossrefGoogle Scholar
  • 23 Levin FR, Evans SM, McDowell D. et al. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 1997; 59: 300-5.
    Google Scholar
  • 24 Diehl A, Sobanski E, Severa L, Georgi A, Nakovics H, Mann K. Alkoholabhängigkeit bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Rückfallschutz oder Suchtverlagerung durch Methylphenidat? Poster. 15. Wissenschaftliche Tagung der Deutschen Gesellschaft für Suchtforschung und Suchttherapie e.V. 2004
    Google Scholar
  • 25 Berger M. Affektive Störungen. In Berger M. (Hrsg). Psychiatrie und Psychotherapie. München, Wien, Baltimore: Urban & Schwarzenberg; 1999
    Google Scholar
  • 26 Faraone S, Biederman J. Do attention deficit hyperactivty disorder and major depression share familial risk factors?. J Nerv Ment Dis 1997; 185: 533-41.
    CrossrefGoogle Scholar
  • 27 Sobanski E, Alm B, Krumm B. Methylphenidatbehandlung bei erwachsenen Patienten mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Bedeutung von Störungssubtyp und psychiatrischer Komorbidität. Nervenarzt. (in Druck).
    Google Scholar
  • 28 Findling RL. Open-label treatment of comorbid depression and attentional disorders with a co-administration of serotonin reuptake inhibitors and psychostimulants in children, dolescents and adults: a case series. J Child Adolesc Psychopharmacol 1996; 06: 165-75.
    CrossrefGoogle Scholar
  • 29 Hornig-Rohan M, Amsterdam JD. Venalfaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 585-9.
    CrossrefGoogle Scholar
  • 30 Brown TE. (ed.). Attention-deficit disorders and comorbidities in children, adolescents and adults. Washington, DC: American Psychiatric Press; 2000
    Google Scholar
  • 31 Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW. et al. Clinical and diagnostic implications of lifetime comorbidity of attention-deficit/hyperactivity disorder in adults with bipolar disorder. Data from the first 1000 STEP-BD participants. Biol Psychiatry 2005; 57: 1467-73.
    CrossrefGoogle Scholar
  • 32 Alm B, Sobanski E. Angststörungen und Komorbidität mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. In Bassler M, Leydig S. (eds). Psychotherapie der Angsterkrankungen. Stuttgart, New York: Georg Thieme Verlag; 2005
    Google Scholar
  • 33 Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N. A clinical and demographic profile of a sample of adults with attention-deficit hyperactivity disorder, residual state. Compr Psychiatry 1990; 31: 416-25.
    CrossrefGoogle Scholar
  • 34 Fichter MM. Anorektische und bulimische Essstörungen. In: Berger M. (ed.). Psychiatrie und Psychotherapie. München, Wien, Baltimore: Urban & Schwarzenberg; 1999
    Google Scholar
  • 35 Schweickert LA, Strober M, Moslowitz A. Efficacy of methylphenidate in bulimia nervosa with co- morbid attention-deficit/hyperactivity disorder. Int J Eat Disord 1997; 21: 299-301.
    CrossrefPubMedGoogle Scholar
  • 36 Dukarm CP. Bulimia nervosa and ADHD:a possible role for stimulant medication. Journal of Womens Health 2005; 14: 345-50.
    CrossrefGoogle Scholar
  • 37 Brown TE, McMullen WJ. Attention Deficit Disorders and Sleep/Arousal Disturbance. Annals N Y Acad Sci 2001; 931: 271-86.
    Google Scholar
  • 38 Sobanski E, Alm B. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Erwachsenen. Ein Überblick. Nervenarzt 2004; 75: 697-715.
    Google Scholar
  • 39 Philipsen A, Feige B, Hesslinger B, Ebert D, Carl C. et al. Sleep in adults with attention deficit hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG. Sleep 2005; 28: 738-45.
    Google Scholar
  • 40 Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ. Symptoms of sleep disorder, inattention and hyperactivity. Sleep 1997; 20: 1185-92.
    CrossrefGoogle Scholar
  • 41 Crabtree VM, Ivanenko A, O’Brien LM, Gozal D. Periodic limb movement disorder of sleep in children. J Sleep Res 2003; 12: 73-81.
    CrossrefGoogle Scholar
  • 42 Wagner ML, Walters AS, Fisher BC. Symptoms of attention-defict/hyperactivity disorder in adults with restless legs syndrome. Sleep 2004; 27: 1499-504.
    CrossrefGoogle Scholar
  • 43 Kooij JJS, Huub AM, Middelkoop AM, VanGils K, Buitelaar JK. The effect of stimulants on nocturnal activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry 2001; 62: 952-5.
    CrossrefGoogle Scholar
  • 44 Thapar A, Harrington R, McGuffin P. Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin-study design. Brit J Psychiatry 2001; 179: 224-9.
    CrossrefGoogle Scholar
  • 45 Babinski LM, Hartsough CS, Lambert NM. Childhood conduct problems, hyperactivity-impulsivity and inattention as predictor of adult criminal activity. J Child Adolesc Psychiatry 1999; 40: 347-55.
    Google Scholar
  • 46 Satterfield JH, Schell A. A prospective study of hyperactive boys with conduct disorder and normal boys: Adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 1997; 36: 1726.
    CrossrefGoogle Scholar
  • 47 Fossati A, Novella L, Donati D, Donini M, Maffei C. History of childhood attention deficit / hyperactivity disorder symptoms and borderline personality disorder:a controlled study. Compr Psychiatry 2002; 43: 369-77.
    CrossrefGoogle Scholar
  • 48 Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderström H, Rastam M. et al. Co-existing disorders in ADHD: Implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 2004; (Suppl. 01) 80-92.
    Google Scholar
  • 49 Spencer TJ, Biederman J, Faraone S, Mick E, Coffey B, Geller D. et al. Impact of tic disorders on ADHD outcome across life cycle: Findings from a large group of adults with and without ADHD. Am J Psychiatry 2001; 158: 611-7.
    CrossrefGoogle Scholar
  • 50 Reimherr FW, Faraone SV, Marchant BK, Robinson RR, Strong R, Dittman R. et al. Geschlechtsunterschiede bei Erwachsenen mit ADHS unter Vorbehandlung und doppelblinder Behandlung mit Atomoxetin. Poster. DGPPN Kongress; Berlin: 2005
    Google Scholar
  • 51 Millstein RE, Wilens J, Spencer TJ. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Attention Disorder 1997; 02: 159-66.
    Google Scholar